Skip to main content
. 2020 Nov 26;14:4079–4088. doi: 10.2147/OPTH.S288224

Table 4.

Acute Phase Treatment

Acute Phase Treatment MOG-IgG + ON AQP4-IgG + ON p-value
Number of episodes treated in our institution, n 25 80
Time from ON symptom onset to IVMP treatment, median (range), days 14 (1–30) 7 (0.5–60) 0.66
PLEX, n of episodes (%) 0 (0.0) 7 (8.75) 0.19

Abbreviations: ON, optic neuritis; MOG-IgG +, myelin oligodendrocyte glycoprotein autoantibody-positive; AQP4-IgG +, aquaporin-4 autoantibody-positive; n, number; IVMP, intravenous methylprednisolone; SD, standard deviation; PLEX, plasma exchange.